BTCS Management
Management criteria checks 3/4
BTCS' CEO is Charles Allen, appointed in Feb 2014, has a tenure of 10.58 years. total yearly compensation is $804.32K, comprised of 51.2% salary and 48.8% bonuses, including company stock and options. directly owns 26.56% of the company’s shares, worth €4.44M. The average tenure of the management team and the board of directors is 6.7 years and 9.9 years respectively.
Key information
Charles Allen
Chief executive officer
US$804.3k
Total compensation
| CEO salary percentage | 51.2% |
| CEO tenure | 10.6yrs |
| CEO ownership | 26.6% |
| Management average tenure | 6.7yrs |
| Board average tenure | 9.9yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$10m |
| Mar 31 2024 | n/a | n/a | US$15m |
| Dec 31 2023 | US$804k | US$411k | US$8m |
| Sep 30 2023 | n/a | n/a | US$2m |
| Jun 30 2023 | n/a | n/a | US$1m |
| Mar 31 2023 | n/a | n/a | -US$5m |
| Dec 31 2022 | US$3m | US$369k | -US$16m |
| Sep 30 2022 | n/a | n/a | -US$10m |
| Jun 30 2022 | n/a | n/a | -US$13m |
| Mar 31 2022 | n/a | n/a | -US$10m |
| Dec 31 2021 | US$10m | US$377k | -US$16m |
| Sep 30 2021 | n/a | n/a | -US$21m |
| Jun 30 2021 | n/a | n/a | -US$18m |
| Mar 31 2021 | n/a | n/a | -US$14m |
| Dec 31 2020 | US$1m | US$361k | -US$3m |
| Sep 30 2020 | n/a | n/a | -US$3m |
| Jun 30 2020 | n/a | n/a | -US$2m |
| Mar 31 2020 | n/a | n/a | -US$2m |
| Dec 31 2019 | US$601k | US$345k | -US$2m |
| Sep 30 2019 | n/a | n/a | -US$1m |
| Jun 30 2019 | n/a | n/a | -US$1m |
| Mar 31 2019 | n/a | n/a | -US$1m |
| Dec 31 2018 | US$256k | US$256k | -US$832k |
| Sep 30 2018 | n/a | n/a | -US$507k |
| Jun 30 2018 | n/a | n/a | -US$11m |
| Mar 31 2018 | n/a | n/a | -US$10m |
| Dec 31 2017 | US$310k | US$235k | -US$45m |
Compensation vs Market: Charles's total compensation ($USD804.32K) is above average for companies of similar size in the German market ($USD508.57K).
Compensation vs Earnings: Charles's compensation has been consistent with company performance over the past year.
CEO
Charles Allen (49 yo)
10.6yrs
Tenure
US$804,323
Compensation
Mr. Charles W. Allen is Independent Director of 60 Degrees Pharmaceuticals, Inc. from July 11, 2023. He serves as Director at Innovation1 Biotech Inc. since December 05, 2022 and serves as its Treasurer an...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 10.6yrs | US$804.32k | 26.56% $ 4.4m | |
| Co-Founder | 10.6yrs | US$471.72k | 10.04% $ 1.7m | |
| Chief Financial Officer | 2.8yrs | US$384.77k | 3.18% $ 531.9k | |
| Chief Technology Officer | 2.6yrs | no data | 2.82% $ 471.9k |
6.7yrs
Average Tenure
48yo
Average Age
Experienced Management: BIC's management team is seasoned and experienced (6.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 10.6yrs | US$804.32k | 26.56% $ 4.4m | |
| Co-Founder | 10.6yrs | US$471.72k | 10.04% $ 1.7m | |
| Independent Director | less than a year | no data | 0.099% $ 16.6k | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Member of Advisory Board | 9.9yrs | no data | no data | |
| Independent Director | 1.9yrs | US$85.00k | 0.30% $ 50.6k |
9.9yrs
Average Tenure
47yo
Average Age
Experienced Board: BIC's board of directors are considered experienced (9.9 years average tenure).